7/24 FINANCE
TREN
BIST10014.252,95▼ 0.00%Japan's Largest Pension Fund May Defy Political PressureUSD/TRY47.1443▲ 0.20%India's Wartime Buying Spree Leaves Behind Cooking Gas GlutEUR/TRY53.7708▲ 0.30%AI War: OpenAI and Google's Ties with Blacklisted Chinese FirmsBTC/USD$63,973.45▲ 1.55%TMSF's Big Move: Selling Birinci Hastanesi Ticari and Economic IntegrityGOLD6.212,68▲ 0.15%The Fed's New Moves: AI's Impact on InflationBRENT$75.67▼ 0.00%Markets Turn Bullish: BIST 100 Starts the Day on a High NoteNvidia's Kyber Project on TrackBIST10014.252,95▼ 0.00%Japan's Largest Pension Fund May Defy Political PressureUSD/TRY47.1443▲ 0.20%India's Wartime Buying Spree Leaves Behind Cooking Gas GlutEUR/TRY53.7708▲ 0.30%AI War: OpenAI and Google's Ties with Blacklisted Chinese FirmsBTC/USD$63,973.45▲ 1.55%TMSF's Big Move: Selling Birinci Hastanesi Ticari and Economic IntegrityGOLD6.212,68▲ 0.15%The Fed's New Moves: AI's Impact on InflationBRENT$75.67▼ 0.00%Markets Turn Bullish: BIST 100 Starts the Day on a High NoteNvidia's Kyber Project on Track
Stock Market

Oncosem Wins 117 Million TL Tender

724FinanceKerem Tufan
Oncosem Wins 117 Million TL Tender

Oncosem Onkologic Systems Industry and Trade Inc. has won the tender for the 24-month chemotherapy drug preparation service for 117 million 583 thousand 168.80 TL. The tender was held by the Ankara Provincial Health Directorate.

Tender Details

  • ■The company's bid was determined to be the most advantageous in economic terms, indicating that the company will undertake the chemotherapy drug preparation service for Ankara Etlik City Hospital.
  • ■The tender is valid for a period of 24 months and the company will provide chemotherapy drug preparation services to the hospital during this period.

    • Company's Market Performance

  • ■Winning the tender may contribute to the company's growth in the health sector.
  • ■The company's financial performance may be strengthened by winning tenders.
    • Oncosem's winning of this tender may contribute to the company's growth in the health sector and strengthen its financial performance. However, the company's responsibilities may also increase with the winning of tenders.
    Kerem Tufan

    Financial Analyst: Kerem Tufan

    Ticari Krediler ve Merkez Bankası Politikaları Direktörü. KOBİ kredilerindeki daralmayı, ticari kredi büyüme hızını ve makroihtiyati tedbirlerin bankacılık sektörüne etkisini analiz eden eski bankacı.

    Disclaimer: The investment information, comments, and recommendations contained herein are not within the scope of investment advisory. Investment advisory services are provided individually by authorized institutions, taking into account the risk and return preferences of individuals. The comments and recommendations contained herein are general in nature. These recommendations may not be suitable for your financial situation and your risk and return preferences. Therefore, making an investment decision based solely on the information contained herein may not produce results that meet your expectations.

    © 2026 724Finance - All Rights Reserved.Original Source: Borsagundem.com.tr